Merida Biosciences
Merida Biosciences develops precision treatments for autoimmune diseases.
$120M Series A ·
Led by Bain Capital Life Sciences · Source: startupintros.com
Funding history ↓Acquired by EEli Lilly on for $2.9B · MSN.
Signals
About Merida Biosciences
The company uses a protein engineering platform to create Fc therapeutics. These therapeutics aim to selectively bind to specific antibodies.
Merida Biosciences | 464 days from website to first raise on record
Money raised, round by round (amounts linked to their source). Pins are dated signals; hover the icons for dates.
Funding rounds
| Date | Round | Amount | Lead | Source |
|---|---|---|---|---|
| Series A | $120M | startupintros.com |
Timeline
Founders and team
DG
Dario Gutierrez Founder & Chief Scientific Officer- MSMark Shlomchik Co-foundersource: meridabio.com
- PBPierre Bruhns Co-foundersource: meridabio.com
Investors
BBain Capital Life Scienceslead investor
BBiotechnology Value Fundlead investor
GGV
PPerceptive Advisors
TThird Rock Ventureslead investor
Companies like Merida Biosciences
GGlycoEra$130M Series B+ · May 2025
DDren Bio$350M Series B+ · Oct 2026AAnaveon$120M Series B+ · Dec 2021
GGate BioSeed · Nov 2023MMozart Therapeutics$25M Series A · Jun 2023
CChai DiscoverySeries B+ · Jul 2026
Other companies backed by Bain Capital Life Sciences
OOMass Therapeutics$310M Series B+ · Oct 2026
AAdvanCell$315M Series B+ · Jul 2026
AAngitia Bio$130M Series B+ · Feb 2026
SSyremis Therapeutics$165M Series A · Dec 2025
CCardurion Pharmaceuticals$260M Series B+ · Jul 2024
AAreteia Therapeutics$75M Series A · Feb 2024
Bain Capital Life Sciences portfolio →
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/merida-biosciences (get a free API key).